FDA's Hamburg Interview on GlaxoSmithKline Plc's Avandia

Loading player, please wait...

Recommended Videos

  • Info

  • Comments

Sept. 23 (Bloomberg) -- Margaret Hamburg, commissioner of the Food and Drug Administration, talks with Bloomberg's Melissa Long and Michael Waldholz about the FDA's decision to restrict the use of GlaxoSmithKline Plc's Avandia. Avandia, once the world's best-selling diabetes drug, will be withdrawn in Europe and restricted in the U.S. after a three-year review of the medicine's heart risks. (Source: Bloomberg)


BTV Channel Finder


ZIP is required for U.S. locations

Bloomberg Television in   change